Growth stocks continue to power market gains, driven by digital transformation and AI-related capital expenditure.
: Given that stocks and bonds are moving in the same direction, investors are increasingly turning to low-cost index funds and ETFs to manage risk.
: High-momentum stocks with specific clinical catalysts include ImmunityBio (IBRX) and Erasca (ERAS) .
Growth stocks continue to power market gains, driven by digital transformation and AI-related capital expenditure.
: Given that stocks and bonds are moving in the same direction, investors are increasingly turning to low-cost index funds and ETFs to manage risk. available stocks to buy
: High-momentum stocks with specific clinical catalysts include ImmunityBio (IBRX) and Erasca (ERAS) . Growth stocks continue to power market gains, driven